Fighting liver cancer takes big financial toll: Study
Out-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.
Feb 2, 2023
0
9
Out-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.
Feb 2, 2023
0
9
Medicare costs for treatment of metastatic prostate cancer have risen sharply within the last 15 years—reflecting increased use of new medications under Medicare Part D, reports a study in Urology Practice.
Dec 20, 2022
0
0
For nearly 10 years, Stacie Dusetzina, Ph.D., a Vanderbilt University professor of Health Policy and Ingram Professor of Cancer Research, has focused her research on one core policy issue that has been of interest to lawmakers ...
Nov 3, 2022
0
2
A new study published in today's issue of the Journal of the American Medical Association (JAMA) analyzes the benefits and harms of prior authorization (PA) policies for Medicare and the impact these policies have on patients ...
Oct 3, 2022
0
6
Enrolling in a higher-cost Medicare Advantage plan may not always get seniors better quality health care, according to a new RAND Corporation study.
Aug 29, 2022
0
60
People with kidney failure who do not choose conservative management and have not received a kidney transplant can undergo either hemodialysis, which is typically performed several times a week at a clinic, or at-home peritoneal ...
Aug 18, 2022
0
4
At its current pace, Medicare's Hospital Insurance trust fund will run out of money in 2028, according to the June 2022 Medicare trustees report. That's a two-year extension on the previous estimate, but experts say it's ...
Aug 10, 2022
0
4
The Inflation Reduction Act contains provisions that are expected to lower drug costs for millions of Americans by allowing Medicare to negotiate some drug prices and by limiting the amount of out-of-pocket drug costs for ...
Aug 9, 2022
0
2
Over 30 million Americans have diabetes, and more than 7 million of them require daily insulin. But the cost of the drug has risen considerably in the last decade. Though U.S. lawmakers are considering policies to address ...
Jul 5, 2022
0
43
Medicare could waste up to $605 million per year on the controversial Alzheimer's drug aducanumab if it is eventually approved for widespread use because it is supplied in vials containing fixed doses that may not be appropriate ...
Jun 27, 2022
1
13